West Pharmaceutical [WST] vs Hologic [HOLX] Detailed Stock Comparison

West Pharmaceutical

NYSE
Loading...

Hologic

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: West Pharmaceutical wins in 9 metrics, Hologic wins in 10 metrics, with 0 ties. Hologic appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricWest PharmaceuticalHologicBetter
P/E Ratio (TTM)40.5727.86Hologic
Price-to-Book Ratio6.663.08Hologic
Debt-to-Equity Ratio10.5252.09West Pharmaceutical
PEG Ratio2.065.78West Pharmaceutical
EV/EBITDA23.6412.47Hologic
Profit Margin (TTM)16.48%13.79%West Pharmaceutical
Operating Margin (TTM)20.87%25.48%Hologic
EBITDA Margin (TTM)20.87%25.48%Hologic
Return on Equity17.72%11.38%West Pharmaceutical
Return on Assets (TTM)10.53%6.69%West Pharmaceutical
Free Cash Flow (TTM)$276.40M$1.15BHologic
Dividend Yield0.38%N/AN/A
1-Year Return-7.87%-15.37%West Pharmaceutical
Price-to-Sales Ratio (TTM)6.593.70Hologic
Enterprise Value$18.66B$15.57BWest Pharmaceutical
EV/Revenue Ratio6.303.86Hologic
Gross Profit Margin (TTM)35.73%56.32%Hologic
Revenue per Share (TTM)$41$18West Pharmaceutical
Earnings per Share (Diluted)$6.69$2.41West Pharmaceutical
Beta (Stock Volatility)1.050.57Hologic
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

West Pharmaceutical vs Hologic Stock Performance Analysis

Loading Price Chart...

West Pharmaceutical
Hologic
West Pharmaceutical Stock Overview | Hologic Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
West Pharmaceutical0.64%7.34%12.07%23.48%23.32%-16.82%
Hologic1.30%3.22%1.95%4.00%12.14%-5.34%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
West Pharmaceutical-7.87%9.34%-8.42%397.65%1,455.58%1,825.02%
Hologic-15.37%6.51%-2.13%82.16%322.59%379.59%

News Based Sentiment: West Pharmaceutical vs Hologic

West Pharmaceutical

News based Sentiment: POSITIVE

West Pharmaceutical Services reported strong Q2 results, exceeding both earnings and revenue estimates, and reaffirmed its full-year guidance. This positive performance has led to increased price targets from analysts and inclusion in a high-growth dividend stock list, signaling a generally positive outlook for the company.

View West Pharmaceutical News Sentiment Analysis

Hologic

News based Sentiment: NEUTRAL

The month's news for Hologic paints a picture of stability rather than dramatic growth. While the stock outperformed the S&P 500 slightly and analyst estimates are trending upward, the overall sentiment is neutral due to the 'Hold' rating and modest gains. The valuation metrics suggest potential value, but don't indicate a strong buy signal.

View Hologic News Sentiment Analysis

Performance & Financial Health Analysis: West Pharmaceutical vs Hologic

MetricWSTHOLX
Market Information
Market Cap i$19.61B$14.94B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i663,1473,267,260
90 Day Avg. Volume i588,0862,018,787
Last Close$273.16$67.91
52 Week Range$187.43 - $352.33$51.90 - $84.39
% from 52W High-22.47%-19.53%
All-Time High$475.35 (Sep 06, 2021)$87.88 (May 01, 2023)
% from All-Time High-42.53%-22.72%
Growth Metrics
Quarterly Revenue Growth0.09%0.01%
Quarterly Earnings Growth0.18%0.00%
Financial Health
Profit Margin (TTM) i0.16%0.14%
Operating Margin (TTM) i0.21%0.25%
Return on Equity (TTM) i0.18%0.11%
Debt to Equity (MRQ) i10.5252.09
Cash & Liquidity
Book Value per Share (MRQ)$40.74$21.79
Cash per Share (MRQ)$7.09$8.47
Operating Cash Flow (TTM) i$676.70M$1.07B
Levered Free Cash Flow (TTM) i$207.85M$760.11M
Dividends
Last 12-Month Dividend Yield i0.38%N/A
Last 12-Month Dividend i$0.83N/A

Valuation & Enterprise Metrics Analysis: West Pharmaceutical vs Hologic

MetricWSTHOLX
Price Ratios
P/E Ratio (TTM) i40.5727.86
Forward P/E i36.0914.23
PEG Ratio i2.065.78
Price to Sales (TTM) i6.593.70
Price to Book (MRQ) i6.663.08
Market Capitalization
Market Capitalization i$19.61B$14.94B
Enterprise Value i$18.66B$15.57B
Enterprise Value Metrics
Enterprise to Revenue i6.303.86
Enterprise to EBITDA i23.6412.47
Risk & Other Metrics
Beta i1.050.57
Book Value per Share (MRQ) i$40.74$21.79

Financial Statements Comparison: West Pharmaceutical vs Hologic

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)WSTHOLX
Revenue/Sales i$766.50M$1.01B
Cost of Goods Sold i$492.60M$628.00M
Gross Profit i$273.90M$377.30M
Research & Development i$19.10M$61.50M
Operating Income (EBIT) i$158.90M$37.90M
EBITDA i$203.40M$121.70M
Pre-Tax Income i$157.00M$-28.50M
Income Tax i$30.20M$-11.10M
Net Income (Profit) i$131.80M$-17.40M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)WSTHOLX
Cash & Equivalents i$509.70M$1.43B
Total Current Assets i$1.68B$3.21B
Total Current Liabilities i$604.60M$989.70M
Long-Term Debt i$282.40M$2.47B
Total Shareholders Equity i$2.93B$4.62B
Retained Earnings i$4.14B$3.03B
Property, Plant & Equipment i$3.28B$939.80M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)WSTHOLX
Operating Cash Flow i$177.40M$28.40M
Capital Expenditures iN/A$-24.70M
Free Cash Flow i$101.90M$129.20M
Debt Repayment i$-300,000$-10.20M
Common Stock Repurchase i$-500,000$-200.00M

Short Interest & Institutional Ownership Analysis

MetricWSTHOLX
Shares Short i1.68M3.11M
Short Ratio i2.922.03
Short % of Float i0.03%0.02%
Average Daily Volume (10 Day) i663,1473,267,260
Average Daily Volume (90 Day) i588,0862,018,787
Shares Outstanding i72.30M231.73M
Float Shares i71.41M220.32M
% Held by Insiders i0.01%0.01%
% Held by Institutions i0.98%1.01%

Dividend Analysis & Yield Comparison: West Pharmaceutical vs Hologic

MetricWSTHOLX
Last 12-Month Dividend i$0.83N/A
Last 12-Month Dividend Yield i0.38%N/A
3-Year Avg Annual Dividend i$0.79N/A
3-Year Avg Dividend Yield i0.07%N/A
3-Year Total Dividends i$2.37N/A
Ex-Dividend DateApr 30, 2025N/A